Search

everythinglearnresearchcommunity

for

Search:↓

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

Finasteride, often used for hair loss, can potentially cause cataracts.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Platelet-rich plasma therapy may have benefits and is generally safe, but more research is needed to confirm its effectiveness and safety.

The document describes skin diseases affecting the outer ear in dogs and cats, their spread to other body parts, and treatment options.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Skin doctors should know about skin and kidney disease links to prevent serious kidney problems.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Isolated limb perfusion is a safe and effective treatment for limb melanoma.

Isolated hyperthermic chemotherapy perfusion for limb melanoma is safe and effective with manageable side effects.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

GLI1 RNA CISH effectively identifies basal cell carcinoma but is less specific for benign follicular tumors.

A super thin DIEP flap can effectively reconstruct scalp defects with good skin coverage and contour.

Erlotinib may cause scarring hair loss.

Recognizing skin symptoms in children can help diagnose and manage serious diseases early.

CRISPR-based tools improve understanding and treatment of skin development and conditions.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

Cetuximab can cause unusual hair growth and hair loss.

EMT and metabolic pathways help cancer cells resist treatment and spread.

Blocking YAP/TAZ could be a new way to treat skin cancer.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

A man with itchy skin lesions and weight loss was diagnosed with a rare skin condition linked to a pancreatic tumor.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.